Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension

Hypertension

Volumn 48, Issue 1, 2006, Pages 25-26

  Feig, Daniel I ^a   Rodriguez Iturbe, Bernardo ^b   Nakagawa, Takahiko ^c   Johnson, Richard J ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; PROTEIN; URIC ACID;

BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY BLOOD VESSEL; LOW BIRTH WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WHITE COAT HYPERTENSION; ADOLESCENT; BLOOD; BLOOD PRESSURE; CHILD; NEPHRON; NEWBORN; NOTE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADOLESCENT; BLOOD PRESSURE; CHILD; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; NEPHRONS; URIC ACID;

EID: 33746028144     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000223447.53155.d5     Document Type: Editorial

References (22)

1. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272:676-680.
2. Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, Risch N, Turner ST, Cox DR, Hunt SC, Weder AB, Boerwinkle E. A meta-analysis of genome-wide linkage scans for hypertension: The National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2003;16:144-147.
3. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Brit Med J. 1989;298:564-567.
4. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease. The role of fetal programming. Hypertension. 2006;47:502-508.
5. Eriksson J, Forsén T, Tuomilehto J, Osmod C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension. 2000;36:790-794.
6. Keller J, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101-118.
7. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-923.
8. Johnson RJ, Feig DI, Kang DH, Herrera-Acosta J. Resurrection of uric acid as a causal risk factor for essential hypertension. Hypertension. 2005;45:18-20.
9. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Johnson RJ. Uric acid is a causal factor in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290:F625-F631.
10. Kang D-H, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888-2897.
11. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang D-H, Finch J, Johnson RJ. Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66:281-287.
12. Siu YP, Leung KT, Tong MKH, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability in lowering serum uric acid level. Am J Kid Dis. 2006;47:51-59.
13. Chang FM, Chow SN, Huang HC, Hsieh FJ, Chen HY, Lee TY, Ouyang PC, Chen YP. The placental transfer and concentration difference in maternal and neonatal serum uric acid at parturition: comparison of normal pregnancy and gestosis. Biol Res Pregnancy Perinatol. 1987;35:35-39.
14. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46:1263-1269.
15. Sanchez-Lozada LG, Tapia E, Johnson RJ, Rodriguez-Iturbe B, Herrera-Acosta J. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney Int Suppl. 2003;86:S9-S14.
16. Franco MCP, Christofalo DMJ, Sawaya AL, Ajzen SA, Sesso R. Effects of low birth weight in 8- to 13-year old children: implications in endothelial function and uric acid levels. Hypertension. 2006;48:45-50.
17. Falkner B, Hulman S, Kushner H. Effect of birth weight on blood pressure and body size in early adolescence. Hypertension. 2004;43:203-207.
18. Feig DI, Johnson RJ. Hyperuricemia in childhood essential hypertension. Hypertension. 2003;42:247-252.
19. Black MJ, Briscoe TA, Constantinou M, Kett MM, Bertram JF. Is there an association between level of adult blood pressure and nephron number or surface area? Kidney Int. 2004;65:582-588.
20. Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand. 2004;181:397-405.
21. Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int. 2005;68:2180-2188.
22. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nature Clinical Practice Nephrology. 2006;1:80-86.